somebody else doing something similar
Maybe some here will eventually get the reason we , and others, are saying goodbye to ASXKazia to de-list from ASX
Oncology-focused drug development company Kazia Therapeutics (ASX:KZA) has surprisingly announced its intention to de-list from the ASX.
Kazia says its board has ultimately determined that the costs, administrative burden and commercial disadvantages of remaining listed on ASX outweigh any benefits of a continued listing.
The company says continued listing would incur considerable costs, including listing fees, at a time when Kazia is seeking to minimise its expenditure.
Further, the board believes that delisting from ASX whilst retaining its NASDAQ listing will enable Kazia to have access to a deeper market that better understands and values biotech businesses, thereby allowing it to more readily raise more capital on better terms from a wider investor base.
Aussie shareholders will be able to sell their ASX shares now, or wait for conversion into NASDAQ shares.
Kazia has an ongoing Phase 2 study (PNOC022, NCT05009992) of paxalisib, an investigational drug for the treatment of diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas (DMGs).
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-17968
-
- There are more pages in this discussion • 1,928 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online